Workflow
海利尔: 海利尔药业集团股份有限公司关于为全资子公司提供担保的进展公告

Core Viewpoint - The company has announced the provision of guarantees for its wholly-owned subsidiaries, Qingdao Hengning Biotechnology Co., Ltd. and Shandong Hailier Chemical Co., Ltd., totaling RMB 150 million to support their credit activities [1][2][8]. Group 1: Guarantee Details - The total guarantee amount for Qingdao Hengning Biotechnology is RMB 50 million, with no prior guarantee balance [1][2]. - The total guarantee amount for Shandong Hailier is RMB 100 million, with an existing guarantee balance of RMB 270.6358 million [1][2]. - The guarantees are within the previously estimated limits and do not require counter-guarantees [1][2]. Group 2: Subsidiary Information - Qingdao Hengning Biotechnology is a wholly-owned subsidiary with a registered capital of RMB 116.66 million, established on July 24, 2019, and focuses on technology services and chemical product production [3][4]. - Shandong Hailier Chemical is also a wholly-owned subsidiary with a registered capital of RMB 51.66 million, established on December 17, 2007, and engages in pesticide production and chemical sales [3][4]. Group 3: Financial Overview - As of the latest audited financials, the total external guarantee amount by the company and its subsidiaries is RMB 3.331 billion, representing 97.29% of the company's audited net assets as of December 31, 2024 [8]. - Both subsidiaries, Hengning and Shandong Hailier, are not classified as dishonest executors [5]. Group 4: Board Decisions - The board of directors approved the proposal for the company to apply for a comprehensive credit limit for 2025 and to provide corresponding guarantee limits during the meetings held on April 28, 2025 [7][8]. - The guarantees are deemed necessary to support the subsidiaries' business development and ensure stable operations, aligning with the company's overall interests and strategic development [7].